Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose

Vaccine. 1999 Apr 23;17(17):2162-5. doi: 10.1016/s0264-410x(99)00012-2.

Abstract

We here studied the antibody response to a booster dose four years after the administration of one single dose of recombinant HB vaccine. Before receiving the booster dose, levels of protective antibodies (anti-HBs) were generally low and 24/41 (59%) individuals lacked detectable antibodies (< 1 IU/L). Within 14 d of booster vaccination, 36/38 (95%) vaccinees showed levels of antibodies > 100 IU/L. Notably, these levels were at least as high as those of a reference group 12 months after initiation of vaccination according to the standard three-dose vaccination at intervals of 0, 1 and 6 months. In conclusion, one single dose of HB vaccine seemed to confer on young healthy individuals a well preserved B cell memory, disclosed as a rapid and strong antibody response to a second dose four years later.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Dose-Response Relationship, Immunologic
  • Female
  • Hepatitis B Antibodies / biosynthesis
  • Hepatitis B Antibodies / blood
  • Hepatitis B Vaccines / administration & dosage*
  • Hepatitis B Vaccines / immunology
  • Humans
  • Immunization Schedule
  • Immunization, Secondary*
  • Male
  • Vaccines, Synthetic / administration & dosage*
  • Vaccines, Synthetic / immunology

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Vaccines
  • Vaccines, Synthetic